Gadoterate meglumine
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Gadoterate Meglumine is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance visibility of body structures. It's administered intravenously as a solution in various vial sizes, manufactured by Fresenius Kabi USA, LLC. This generic drug, approved under ANDA215304, helps diagnose conditions by improving MRI scans. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Gadoterate meglumine
Access the FDA dataset for Gadoterate meglumine — ANDA 210016 submitted by Mylan Institutional LLC
Modified Jun 29, 2026